The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities

P Nombela, B Miguel-López, S Blanco - Molecular cancer, 2021 - Springer
RNA modifications have recently emerged as critical posttranscriptional regulators of gene
expression programmes. Significant advances have been made in understanding the …

FTO in cancer: functions, molecular mechanisms, and therapeutic implications

Y Li, R Su, X Deng, Y Chen, J Chen - Trends in cancer, 2022 - cell.com
N 6-methyladenosine (m 6 A) is the most abundant internal modification in mRNA that
affects RNA processing, stability, and translation. Discovered as the first RNA m 6 A …

Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine

C Xue, Q Chu, Q Zheng, S Jiang, Z Bao, Y Su… - Signal transduction and …, 2022 - nature.com
Cancer is one of the major diseases threatening human life and health worldwide.
Epigenetic modification refers to heritable changes in the genetic material without any …

[HTML][HTML] The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma

S Qin, Y Mao, X Chen, J **ao, Y Qin… - International Journal of …, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths
worldwide. HCC has high rates of death and recurrence, as well as very low survival rates …

The role of RNA modification in hepatocellular carcinoma

Q Feng, D Wang, T Xue, C Lin, Y Gao, L Sun… - Frontiers in …, 2022 - frontiersin.org
Hepatocellular carcinoma (HCC) is a highly mortal type of primary liver cancer. Abnormal
epigenetic modifications are present in HCC, and RNA modification is dynamic and …

Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma

A Chen, VX Zhang, Q Zhang, KMF Sze, L Tian… - Gut, 2025 - gut.bmj.com
Objective Fat mass and obesity-associated protein (FTO), an eraser of N 6-methyadenosine
(m6A), plays oncogenic roles in various cancers. However, its role in hepatocellular …

The potential role of N6-methyladenosine (m6A) demethylase fat mass and obesity-associated gene (FTO) in human cancers

J Wang, L Chen, P Qiang - OncoTargets and therapy, 2020 - Taylor & Francis
Abstract N6-methyladenosine (m6A) demethylase fat mass and obesity-associated gene
(FTO), previously recognized to be related with obesity and diabetes, was gradually …

Roles of N6‐Methyladenosine demethylase FTO in malignant tumors progression

QK Zheng, C Ma, I Ullah, K Hu, RJ Ma… - OncoTargets and …, 2021 - Taylor & Francis
In 2007, the fat mass and obesity-associated (FTO) gene was discovered initially to regulate
body mass index and obesity and was subsequently found to be the first mRNA N6 …

Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value

H Liu, G Qin, Y Ji, X Wang, H Bao, X Guan… - Journal of Orthopaedic …, 2021 - Springer
Background Osteosarcoma is a disease with high mortality in children and adolescents, and
metastasis is one of the important clinical features of osteosarcoma. N 6-Methyladenosine …

RNA m6A methylation regulators in liver cancer

Q Xu, N Ren, L Ren, Y Yang, J Pan, H Shang - Cancer Cell International, 2024 - Springer
Liver cancer is one of the most common cancers in the world and a primary cause of cancer-
related death. In recent years, despite the great development of diagnostic methods and …